Mapime 250mg Injection
Marketer
Mapra Laboratories Pvt Ltd
Salt Composition
Cefepime (250mg)
Overview Mapime 250mg Injection
Cefapime 250mg injection is a powerful antibacterial agent effective against various bacterial strains. It's indicated for serious infections affecting the skin, respiratory system, gastrointestinal tract, urinary system, and bloodstream. Its mechanism involves bacterial cell destruction, thus resolving the infection. Importantly, it's ineffective against viral infections. Cefapime 250mg injection is frequently administered to hospitalized patients with critical illnesses. Intravenous delivery, either via infusion or direct injection, is overseen by a healthcare professional. Dosage is tailored to infection severity, location, and type. Complete the prescribed course, even with rapid symptom improvement, to prevent relapse or worsening. Premature cessation may lead to treatment failure. Potential adverse effects include skin reactions (rash, itching), gastrointestinal upset (nausea, vomiting, diarrhea), headache, fever, and local injection site inflammation. These are usually transient, resolving as treatment progresses. Report persistent or bothersome side effects to your physician. Prior to treatment, disclose any kidney or liver conditions, or antibiotic allergies. Regular blood tests to assess kidney function may be recommended during treatment. Generally considered safe during pregnancy and lactation under medical supervision.
Uses of Mapime 250mg Injection
Managing life-threatening bacterial infections
Major Benefits of Mapime 250mg Injection:
This medication will be administered by your healthcare provider. Self-medication is strongly discouraged.
Common Side effects of Mapime 250mg Injection:
- Injection site reactions (pain, swelling, redness)
- Diarrhea
- Increased white blood cell count (eosinophils)
- Injection site phlebitis
- Skin rash
- Increased liver enzymes
- Positive Coombs test
- Increased prothrombin time
- Decreased phosphate level in blood
- Increased partial thromboplastin time (PTT)
How to use Mapime 250mg Injection:
The medication will be administered by your physician or their qualified assistant; self-medication is strongly discouraged.
How Mapime 250mg Injection works:
Cefapime 250mg injection is a bactericidal antibiotic. Its mechanism of action involves disrupting bacterial cell wall synthesis, a process essential for bacterial viability.
SAFETY ADVICE
AlcoholSAFE
Concurrent use of Mapime 250mg Injection and alcohol does not produce adverse reactions.
PregnancySAFE IF PRESCRIBED
Administering Mapime 250mg Injection during gestation is typically deemed safe. Preclinical trials in animals revealed minimal or absent harm to offspring; nevertheless, clinical data in humans are scarce.
Breast feedingSAFE IF PRESCRIBED
Mapime 250mg Injection is considered safe for breastfeeding mothers. Research in humans indicates minimal drug transfer to breast milk, posing no apparent risk to the infant. However, extended use of Mapime 250mg Injection should be avoided due to potential side effects including skin rashes and diarrhea.
DrivingCONSULT YOUR DOCTOR
The effect of Mapime 250mg Injection on driving ability is unknown. Refrain from driving if you experience symptoms impairing concentration or reaction time.
KidneyCAUTION
For individuals with impaired kidney function, administering Mapime 250mg Injection requires careful consideration. A modified dosage of Mapime 250mg Injection might be necessary. Physician consultation is advised.
LiverSAFE IF PRESCRIBED
The use of Mapime 250mg Injection in individuals with hepatic impairment is likely safe. Preliminary evidence indicates dose modification may be unnecessary. Physician consultation is recommended.
What if you forget to take Mapime 250mg Injection :
Omit a Mapime 250mg Injection dose? Seek medical advice immediately.
Facts to Know About Mapime 250mg Injection
| Label | Value |
|---|---|
| Chemical Classification | Cephalosporins (3rd and 4th generation) |
| Developing Habits | No. |
| Treatment Category | Antimicrobial Agents |
| Actions | Fourth-Generation Cephalosporins |
3,018 People bought this recently